Design	O
,	O
synthesis	O
,	O
and	O
evaluation	B:C0220825
of	O
curcumin	O
derivatives	O
as	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	O
against	O
oxidative	O
death	I:C3893307
.	O

Design	O
,	O
synthesis	O
,	O
and	O
evaluation	O
of	O
curcumin	B:C0010467
derivatives	O
as	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	O
against	O
oxidative	O
death	I:C3893307
.	O

Design	O
,	O
synthesis	O
,	O
and	O
evaluation	O
of	O
curcumin	O
derivatives	B:C0243072
as	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	O
against	O
oxidative	O
death	I:C3893307
.	O

Design	O
,	O
synthesis	O
,	O
and	O
evaluation	O
of	O
curcumin	O
derivatives	O
as	O
nuclear	B:C0289507
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	O
against	O
oxidative	O
death	I:C3893307
.	O

Design	O
,	O
synthesis	O
,	O
and	O
evaluation	O
of	O
curcumin	O
derivatives	O
as	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	B:C0524828
against	O
oxidative	O
death	I:C3893307
.	O

Design	O
,	O
synthesis	O
,	O
and	O
evaluation	O
of	O
curcumin	O
derivatives	O
as	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	O
against	O
oxidative	B:C3893307
death	I:C3893307
.	O

Activation	O
of	O
nuclear	B:C0289507
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
(	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
)	O
has	O
been	O
proven	O
to	O
be	O
an	O
effective	O
means	O
to	O
prevent	O
the	O
development	O
of	O
cancer	O
,	O
and	O
natural	O
curcumin	O
stands	O
out	O
as	O
a	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activator	O
and	O
cancer	O
chemopreventive	O
agent	I:C1516463
.	O

Activation	O
of	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
(	O
nuclear	B:C0289507
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
)	O
has	O
been	O
proven	O
to	O
be	O
an	O
effective	O
means	O
to	O
prevent	O
the	O
development	O
of	O
cancer	O
,	O
and	O
natural	O
curcumin	O
stands	O
out	O
as	O
a	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activator	O
and	O
cancer	O
chemopreventive	O
agent	I:C1516463
.	O

Activation	O
of	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
(	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
)	O
has	O
been	O
proven	O
to	O
be	O
an	O
effective	O
means	O
to	O
prevent	O
the	O
development	O
of	O
cancer	B:C0006826
,	O
and	O
natural	O
curcumin	O
stands	O
out	O
as	O
a	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activator	O
and	O
cancer	O
chemopreventive	O
agent	I:C1516463
.	O

Activation	O
of	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
(	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
)	O
has	O
been	O
proven	O
to	O
be	O
an	O
effective	O
means	O
to	O
prevent	O
the	O
development	O
of	O
cancer	O
,	O
and	O
natural	O
curcumin	B:C0010467
stands	O
out	O
as	O
a	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activator	O
and	O
cancer	O
chemopreventive	O
agent	I:C1516463
.	O

Activation	O
of	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
(	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
)	O
has	O
been	O
proven	O
to	O
be	O
an	O
effective	O
means	O
to	O
prevent	O
the	O
development	O
of	O
cancer	O
,	O
and	O
natural	O
curcumin	O
stands	O
out	O
as	O
a	O
potent	O
nuclear	B:C0289507
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activator	O
and	O
cancer	O
chemopreventive	O
agent	I:C1516463
.	O

Activation	O
of	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
(	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
)	O
has	O
been	O
proven	O
to	O
be	O
an	O
effective	O
means	O
to	O
prevent	O
the	O
development	O
of	O
cancer	O
,	O
and	O
natural	O
curcumin	O
stands	O
out	O
as	O
a	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activator	O
and	O
cancer	B:C0006826
chemopreventive	O
agent	I:C1516463
.	O

Activation	O
of	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
(	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
)	O
has	O
been	O
proven	O
to	O
be	O
an	O
effective	O
means	O
to	O
prevent	O
the	O
development	O
of	O
cancer	O
,	O
and	O
natural	O
curcumin	O
stands	O
out	O
as	O
a	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activator	O
and	O
cancer	O
chemopreventive	B:C1516463
agent	I:C1516463
.	O

In	O
this	O
study	B:C2603343
,	O
we	O
synthesized	O
a	O
series	O
of	O
curcumin	O
analogs	O
by	O
introducing	O
the	O
geminal	O
dimethyl	O
substituents	O
on	O
the	O
active	O
methylene	O
group	O
to	O
find	O
more	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	O
against	O
oxidative	O
death	I:C3893307
.	O

In	O
this	O
study	O
,	O
we	O
synthesized	O
a	O
series	O
of	O
curcumin	B:C0010467
analogs	O
by	O
introducing	O
the	O
geminal	O
dimethyl	O
substituents	O
on	O
the	O
active	O
methylene	O
group	O
to	O
find	O
more	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	O
against	O
oxidative	O
death	I:C3893307
.	O

In	O
this	O
study	O
,	O
we	O
synthesized	O
a	O
series	O
of	O
curcumin	O
analogs	B:C0243071
by	O
introducing	O
the	O
geminal	O
dimethyl	O
substituents	O
on	O
the	O
active	O
methylene	O
group	O
to	O
find	O
more	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	O
against	O
oxidative	O
death	I:C3893307
.	O

In	O
this	O
study	O
,	O
we	O
synthesized	O
a	O
series	O
of	O
curcumin	O
analogs	O
by	O
introducing	O
the	O
geminal	O
dimethyl	O
substituents	O
on	O
the	O
active	O
methylene	O
group	O
to	O
find	O
more	O
potent	O
nuclear	B:C0289507
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	O
against	O
oxidative	O
death	I:C3893307
.	O

In	O
this	O
study	O
,	O
we	O
synthesized	O
a	O
series	O
of	O
curcumin	O
analogs	O
by	O
introducing	O
the	O
geminal	O
dimethyl	O
substituents	O
on	O
the	O
active	O
methylene	O
group	O
to	O
find	O
more	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	B:C0524828
against	O
oxidative	O
death	I:C3893307
.	O

In	O
this	O
study	O
,	O
we	O
synthesized	O
a	O
series	O
of	O
curcumin	O
analogs	O
by	O
introducing	O
the	O
geminal	O
dimethyl	O
substituents	O
on	O
the	O
active	O
methylene	O
group	O
to	O
find	O
more	O
potent	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
and	O
cytoprotectors	O
against	O
oxidative	B:C3893307
death	I:C3893307
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	B:C0054858
-	O
type	O
curcumin	O
analog	O
(	O
compound	O
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	O
activity	O
against	O
the	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	O
of	O
HepG2	O
cells	I:C2717940
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	O
-	O
type	O
curcumin	B:C0010467
analog	O
(	O
compound	O
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	O
activity	O
against	O
the	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	O
of	O
HepG2	O
cells	I:C2717940
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	O
-	O
type	O
curcumin	O
analog	B:C0243071
(	O
compound	O
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	O
activity	O
against	O
the	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	O
of	O
HepG2	O
cells	I:C2717940
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	O
-	O
type	O
curcumin	O
analog	O
(	O
compound	B:C1254351
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	O
activity	O
against	O
the	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	O
of	O
HepG2	O
cells	I:C2717940
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	O
-	O
type	O
curcumin	O
analog	O
(	O
compound	O
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	B:C1254351
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	O
activity	O
against	O
the	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	O
of	O
HepG2	O
cells	I:C2717940
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	O
-	O
type	O
curcumin	O
analog	O
(	O
compound	O
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	B:C0314668
and	O
cytoprotective	O
activity	O
against	O
the	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	O
of	O
HepG2	O
cells	I:C2717940
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	O
-	O
type	O
curcumin	O
analog	O
(	O
compound	O
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	B:C0524828
activity	O
against	O
the	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	O
of	O
HepG2	O
cells	I:C2717940
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	O
-	O
type	O
curcumin	O
analog	O
(	O
compound	O
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	O
activity	O
against	O
the	O
tert	B:C0076150
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	O
of	O
HepG2	O
cells	I:C2717940
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	O
-	O
type	O
curcumin	O
analog	O
(	O
compound	O
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	O
activity	O
against	O
the	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	B:C0076150
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	O
of	O
HepG2	O
cells	I:C2717940
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	O
-	O
type	O
curcumin	O
analog	O
(	O
compound	O
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	O
activity	O
against	O
the	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	B:C0007587
of	O
HepG2	O
cells	I:C2717940
.	O

The	O
geminally	O
dimethylated	O
and	O
catechol	O
-	O
type	O
curcumin	O
analog	O
(	O
compound	O
3	I:C1254351
)	O
was	O
identified	O
as	O
a	O
promising	O
lead	O
molecule	I:C1254351
in	O
terms	O
of	O
its	O
increased	O
stability	O
and	O
cytoprotective	O
activity	O
against	O
the	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
(	O
tert	O
-	I:C0076150
butyl	I:C0076150
hydroperoxide	I:C0076150
)	O
-	O
induced	O
death	O
of	O
HepG2	B:C2717940
cells	I:C2717940
.	O

Mechanism	O
studies	B:C2603343
indicate	O
that	O
its	O
cytoprotective	O
effects	O
are	O
mediated	O
by	O
activating	O
the	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
signaling	O
pathway	I:C0037080
in	O
the	O
Michael	O
acceptor	I:C1254351
-	O
and	O
catechol	O
-	O
dependent	O
manners	O
.	O

Mechanism	O
studies	O
indicate	O
that	O
its	O
cytoprotective	B:C0524828
effects	O
are	O
mediated	O
by	O
activating	O
the	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
signaling	O
pathway	I:C0037080
in	O
the	O
Michael	O
acceptor	I:C1254351
-	O
and	O
catechol	O
-	O
dependent	O
manners	O
.	O

Mechanism	O
studies	O
indicate	O
that	O
its	O
cytoprotective	O
effects	O
are	O
mediated	O
by	O
activating	O
the	O
nuclear	B:C0289507
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
signaling	O
pathway	I:C0037080
in	O
the	O
Michael	O
acceptor	I:C1254351
-	O
and	O
catechol	O
-	O
dependent	O
manners	O
.	O

Mechanism	O
studies	O
indicate	O
that	O
its	O
cytoprotective	O
effects	O
are	O
mediated	O
by	O
activating	O
the	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
signaling	B:C0037080
pathway	I:C0037080
in	O
the	O
Michael	O
acceptor	I:C1254351
-	O
and	O
catechol	O
-	O
dependent	O
manners	O
.	O

Mechanism	O
studies	O
indicate	O
that	O
its	O
cytoprotective	O
effects	O
are	O
mediated	O
by	O
activating	O
the	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
signaling	O
pathway	I:C0037080
in	O
the	O
Michael	B:C1254351
acceptor	I:C1254351
-	O
and	O
catechol	O
-	O
dependent	O
manners	O
.	O

Mechanism	O
studies	O
indicate	O
that	O
its	O
cytoprotective	O
effects	O
are	O
mediated	O
by	O
activating	O
the	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
signaling	O
pathway	I:C0037080
in	O
the	O
Michael	O
acceptor	I:C1254351
-	O
and	O
catechol	B:C0054858
-	O
dependent	O
manners	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	B:C0009968
and	O
iron	O
ion	O
chelators	O
that	O
the	O
two	O
metal	O
ion	O
-	O
mediated	O
oxidations	O
of	O
compound	O
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	O
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	B:C0302583
ion	O
chelators	O
that	O
the	O
two	O
metal	O
ion	O
-	O
mediated	O
oxidations	O
of	O
compound	O
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	O
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	O
ion	B:C0022023
chelators	O
that	O
the	O
two	O
metal	O
ion	O
-	O
mediated	O
oxidations	O
of	O
compound	O
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	O
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	O
ion	O
chelators	B:C0007974
that	O
the	O
two	O
metal	O
ion	O
-	O
mediated	O
oxidations	O
of	O
compound	O
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	O
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	O
ion	O
chelators	O
that	O
the	O
two	O
metal	B:C0025552
ion	O
-	O
mediated	O
oxidations	O
of	O
compound	O
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	O
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	O
ion	O
chelators	O
that	O
the	O
two	O
metal	O
ion	B:C0022023
-	O
mediated	O
oxidations	O
of	O
compound	O
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	O
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	O
ion	O
chelators	O
that	O
the	O
two	O
metal	O
ion	O
-	O
mediated	O
oxidations	B:C0030011
of	O
compound	O
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	O
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	O
ion	O
chelators	O
that	O
the	O
two	O
metal	O
ion	O
-	O
mediated	O
oxidations	O
of	O
compound	B:C1254351
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	O
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	O
ion	O
chelators	O
that	O
the	O
two	O
metal	O
ion	O
-	O
mediated	O
oxidations	O
of	O
compound	O
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	B:C0034435
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	O
ion	O
chelators	O
that	O
the	O
two	O
metal	O
ion	O
-	O
mediated	O
oxidations	O
of	O
compound	O
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	O
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	B:C0289507
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	O
.	O

Additionally	O
,	O
we	O
verified	O
by	O
using	O
copper	O
and	O
iron	O
ion	O
chelators	O
that	O
the	O
two	O
metal	O
ion	O
-	O
mediated	O
oxidations	O
of	O
compound	O
3	I:C1254351
to	O
its	O
corresponding	O
electrophilic	O
o-quinone	O
,	O
contribute	O
significantly	O
to	O
its	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
-	O
dependent	O
cytoprotection	B:C0524828
.	O

This	O
work	O
provides	O
an	O
example	O
of	O
successfully	O
designing	O
natural	O
curcumin	B:C0010467
-	O
directed	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
by	O
a	O
stability	O
-	O
increasing	O
and	O
proelectrophilic	O
strategy	O
.	O

This	O
work	O
provides	O
an	O
example	O
of	O
successfully	O
designing	O
natural	O
curcumin	O
-	O
directed	O
nuclear	B:C0289507
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
by	O
a	O
stability	O
-	O
increasing	O
and	O
proelectrophilic	O
strategy	O
.	O

This	O
work	O
provides	O
an	O
example	O
of	O
successfully	O
designing	O
natural	O
curcumin	O
-	O
directed	O
nuclear	O
factor	I:C0289507
erythroid	I:C0289507
-	I:C0289507
2	I:C0289507
-	I:C0289507
related	I:C0289507
factor	I:C0289507
2	I:C0289507
activators	O
by	O
a	O
stability	B:C0314668
-	O
increasing	O
and	O
proelectrophilic	O
strategy	O
.	O

